IPO Listed — 09 Dec 2025
Listing Price: ₹140 (+12.9% vs ₹124)
Aequs IPO Review
Aequs IPO has been reviewed by 17 analysts, and the overall consensus is Strong Apply — carrying a score of 100. Out of the 17 analysts who have covered this IPO, 17 recommend subscribing — reflecting a mixed view from the analyst community.
The issue is priced in the band of ₹₹118 to ₹124 per share per share , with a minimum application size of 120 shares . Subscription ran from 03 Dec 2025 to 05 Dec 2025. As of now, the grey market premium (GMP) for Aequs IPO is quoting at ₹16 (13%), which gives a preliminary sense of how the street is pricing the listing — though GMP is unofficial and can swing sharply before the listing date. Scroll down for the full analyst breakdown and analyst-wise verdicts.
Table of Contents
Recommend Subscribe
Based on 17 analyst reviews
Higher consensus indicates broader analyst agreement.
Analyst Review
Latest IPO Reviews
Frequently Asked Questions
Should I apply for Aequs IPO?
Based on analyst coverage tracked on this page, the overall verdict for Aequs IPO is Strong Apply. Out of 17 analysts who have reviewed this IPO, 17 recommend subscribing. Always cross-check with the full analyst reviews below and consult a SEBI-registered advisor before making any investment decision.
What does the score of 100 mean for Aequs IPO?
The score of 100 is an aggregate of all analyst ratings tracked for Aequs IPO. A score in this range indicates strong analyst confidence — most analysts are recommending a subscribe. Scroll down to read individual analyst verdicts for more context.
What was the actual listing price of Aequs IPO?
Aequs IPO listed on December 9, 2025 at ₹140 , against the issue price of ₹124 — a gain of +12.9% (₹16 per share). View the full GMP history page for day-wise pre-listing trends.
What is the price band and lot size of Aequs IPO?
Aequs IPO was priced at ₹₹118 to ₹124 per share per share. The minimum lot size is 120 shares. Subscription ran from 03 Dec 2025 to 05 Dec 2025.
Explore Aequs IPO Further
Track every stage of this IPO:
Discussion 0
No comments yet
Be the first to share your thoughts!